Even though access to molecular biology has increased since previous reviews, very few cases reported the search for a TFE3 translocation, a TSC1 or TSC2 loss of function mutations or even no FCLN mutation, considered to be the more recent genomic alterations described in PEComas. Here, TSC1 is linked to neoplasm with perivascular epithelioid cell differentiation.